Monthly Archives: April 2026

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Ramipril 1.25mg capsules. MSN/2026/022 Tier 2 – Medium impact Date of issue: 23 April 2026 There are intermittent supply issues with ramipril 1.25mg capsules until the end of May 2026. Ramipril 1.25mg and 2.5mg tablets and ramipril oral solution remain available [...]

The post Medicine Supply Notification: Ramipril 1.25mg capsules appeared first on Community Pharmacy England.

NHS.net Connect is replacing NHSmail, as announced previously. As part of this change, many community pharmacy teams will soon see a new NHS.net homepage called the Launchpad. The move to NHS.net Connect introduces a refreshed look and some improved features. The aim is to make communication and collaboration across the NHS easier. What is the [...]

The post New NHS.net Connect Launchpad homepage – rolling out appeared first on Community Pharmacy England.

Deadline upcoming Community Pharmacy England previously published updated guidance and support to help community pharmacy owners complete the Data Security and Protection Toolkit (DSPTK) 2026. Completing the Toolkit is how pharmacies make their annual information governance (IG) declaration. It is a mandatory requirement under the NHS Terms of Service and must be completed by 30th [...]

The post Data Security and Protection Toolkit 2026: Are you working through it? appeared first on Community Pharmacy England.

Update 28/05/26 – The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocol (SSP) for Ramipril 1.25mg capsules (SSP087) was due to expire 29 May 2026 but has been further extended to Friday 24 July 2026. In response to a significant ongoing disruption to the supply of Ramipril [...]

The post SSP for Ramipril 1.25mg capsules extended appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Hiprex 1g tablets (Doncaster Pharma Limited) Drug alert number: EL(26)A/20 Date issued: 22 April 2026 Doncaster Pharma Limited has informed the MHRA of an error related to the Braille embossing on the outer packaging of the above mentioned parallel imported batches of Hiprex 1 g tablets (POM). It was identified [...]

The post MHRA Class 4 Medicines Defect Notification: Hiprex 1g tablets (Doncaster Pharma Ltd) appeared first on Community Pharmacy England.